FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to biotechnology and represents peptides for obtaining antibodies which induce death of activated T-cells. Also described are methods of obtaining antibodies and compounds-candidates, inducing death of activated T-cells, based on application of peptides by the invention. Described are pharmaceutical compositions, containing peptides by the invention.
EFFECT: peptides by the invention can be efficiently used for treatment of autoimmune and cancer diseases, transplant rejection and allergic diseases caused by activated T-cells.
8 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES | 2005 |
|
RU2482131C2 |
| BINDING POLYPEPTIDES AND USE THEREOF | 2006 |
|
RU2470941C2 |
| P-SELECTIN GLYCOPROTEIN LIGAND 1 MODULATORS | 2004 |
|
RU2407539C2 |
| APOPTOSIS DETECTION TECHNIQUES AND REAGENTS | 2007 |
|
RU2450273C2 |
| HUMAN ANTIBODIES WITH HIGH AFFINITY TO HUMAN IL-4 RECEPTORS | 2009 |
|
RU2539774C2 |
| ANTIBODIES AND CHIMERIC ANTIGENIC RECEPTORS SPECIFIC TO CD19 | 2015 |
|
RU2741105C2 |
| APPLICATION OF ANTI-CD40-ANTIBODIES | 2006 |
|
RU2442606C2 |
| HIGH-AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR | 2014 |
|
RU2663106C2 |
| MICA BINDING AGENTS | 2013 |
|
RU2656183C2 |
| MYBL2 EPITOPE PEPTIDES AND VACCINES CONTAINING THEM | 2009 |
|
RU2496787C2 |
